Axsome Therapeutics

AXSM | NASDAQ | 9 Sledující

$105.16

0.50%

$0.52

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 USD	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	385,693 +42.53%	270,600 +440.80%	50,037 -	0 -
Cost of revenue	33,303 +27.77%	26,065 +401.48%	5,198 +349.75%	1,156 -
Gross profit	352,390 +44.11%	244,535 +445.36%	44,840 +3,979.98%	-1,156 -
Operating expense	632,952 +32.87%	476,360 +115.22%	221,340 +77.49%	124,707 -
Operating income	-280,562 -21.02%	-231,825 -31.34%	-176,501 -41.53%	-124,707 -
Pretax Income	-287,131 -20.50%	-238,278 -27.33%	-187,134 -43.50%	-130,403 -
Tax Provision	85 -91.15%	960 -90.97%	10,633 +134.18%	4,540 -
Net income	-287,216 -20.05%	-239,238 -20.97%	-197,766 -46.56%	-134,943 -
EPS	-5.99 -13.66%	-5.27 -8.44%	-4.86 -35.38%	-3.59 -
Diluted EPS	-5.99 -13.66%	-5.27 -8.44%	-4.86 -35.38%	-3.59 -
Average Shares	47,914 +5.48%	45,425 +11.73%	40,656 +8.07%	37,619 -
Diluted Average Shares	47,914 +5.48%	45,425 +11.73%	40,656 +8.07%	37,619 -
EBIT	-280,562 -21.02%	-231,825 -28.94%	-179,799 -44.18%	-124,707 -
EBITDA	-280,562 -24.70%	-224,991 -29.13%	-174,235 -41.02%	-123,551 -

Soubory cookie používáme ke zlepšení prohlížení na webu.